Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1108735

	registered interest
	date	01/04/2019
	answering body	Ministry of Defence
	answering dept id	11
	answering dept short name	Defence
	answering dept sort name	Defence
	hansard heading	Animal Experiments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Defence, if he will publish a response to Early Day Motion 2113 entitled Use of animals for warfare experiments.
	tabling member constituency	Glasgow North
	tabling member printed	Patrick Grady
	uin	239267
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>Animal experiments at the Defence Science and Technology Laboratory (Dstl) at Porton Down are conducted under the terms of the Animals (Scientific Procedures) Act (ASPA) 1986 and are licensed by the Home Office. The Ministry of Defence (MOD) does not conduct animal experiments for the development or testing of offensive weapons, and the Home Office does not grant licences for these purposes. Dstl fully complies with the ASPA.</p><p>Animals are used in experiments for the development of new vaccines, treatments or medical procedures - results of the research using animals at Dstl Porton Down will not only save the lives of UK service personnel but can also benefit civilians. It is MOD policy that all medical products for use by service personnel are licensed in the same way as any other pharmaceutical drug. Dstl's remit to provide safe and effective countermeasures requires some testing in animals in order to meet regulatory requirements.</p><p>Dstl Porton Down currently uses less than half of one per cent of the total number of animals used in experimentation in the UK, and works to the animal welfare standards set out in the Guidance on the Operation of the ASPA, and the Code of Practice for the housing and care of animals bred, supplied or used for scientific purposes. Dstl has an active programme to minimise the use of animals in experiments, in accordance with the principles of the 3Rs (reduction, refinement and replacement).</p><p>It is not normal practice for the Government to respond to Early Day Motions unless an MP has secured a debate on the motion.</p> answering member constituency Pudsey answering member printed Stuart Andrew question first answered 09/04/2019 16:56:30 answering member 4032 label Biography information for Stuart Andrew
	tabling member	4432 label Biography information for Patrick Grady

1109775

	registered interest
	date	04/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will issue a response to Early Day Motion 1832, on legalisation of medical cannabis.
	tabling member constituency	Glasgow North
	tabling member printed	Patrick Grady
	uin	241057
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>The Government is clear that the decision to prescribe a cannabis-based product for medicinal use should only be made where it is clinically appropriate and in the best interest of the patient. This will be subject to local National Health Service governance and funding arrangements for prescribing unlicensed medicines, and patients will not be able to be prescribed such products by their general practitioner – and would require referral to a specialist clinician on the basis of clinical need.</p><p>The evidence base for cannabis-based products for medicinal use is still developing. However, the changes to the law are designed to encourage further research and the National Institute for Health Research has issued two calls for research proposals to rapidly advance knowledge in this area and remains open to research proposals outside of these calls in this priority area.</p><p>Interim clinical guidance, issued by the Royal College of Physicians, British Paediatric Neurology Association and Association of British Neurologists is based on the best available international evidence and reflects clinical guidance that has been published in other jurisdictions. This guidance will be updated and replaced in October 2019 by that commissioned from the National Institute for Health and Care Excellence.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 09/04/2019 14:40:03 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4432 label Biography information for Patrick Grady

1109730

	registered interest
	date	04/04/2019
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Biofuels
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, if he will issue a response to Early Day Motion 1771, on subsidies for biomass electricity generation.
	tabling member constituency	Glasgow North
	tabling member printed	Patrick Grady
	uin	241056
	answer	answer is ministerial correction date of answer 09/04/2019 answer text <p>Sustainable biomass has an important role to play in our electricity mix as it can help balance demand on the grid by being dispatchable, balancing out intermittent renewables like solar and wind.</p><p> </p><p>We are committed to keeping energy costs as low as possible and subsidies for biomass are monitored through the Levy Control Framework. Biomass plants only receive subsidy for the electricity output which complies with our sustainability criteria</p><p> </p><p>We have consistently stated that we see the use of biomass conversions as a transitional technology. We have announced that support for coal to biomass conversions will end in 2027 and we will be consulting on making coal to biomass conversions ineligible for future allocation rounds of the Contract for Difference scheme in due course.</p> answering member constituency Devizes answering member printed Claire Perry question first answered 09/04/2019 16:01:25 answering member 3974 label Biography information for Claire Perry
	tabling member	4432 label Biography information for Patrick Grady